Share this Page:
On 1st December 2025, the government announced a new UK-US trade deal for medicines. The deal includes an agreement to zero tariffs on UK pharmaceutical exports and preferential rates for MedTech exports.
The government also announced that it will invest around 25% more in innovative, safe, and effective treatments.
The Charity Medicines Access Coalition (CMAC), of which Action Kidney Cancer are members, has issued a press release about the UK-US trade deal for medicines, and what it means for access the medicines in the UK.
